<!doctype html>
<html lang="en">
  <head>
    <!-- Required meta tags -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

    <!-- Bootstrap CSS -->
    <link rel="stylesheet" href="css/bootstrap.min.css">
    <link rel="stylesheet" href="css/style.css">

    <title>Agios</title>
  </head>
  <body>
    <nav class="navbar navbar-expand-lg navbar-dark">
      <div class="container">
        <a class="navbar-brand" href="index.html">
          <img src="images/logo.png" />
        </a>

        <ul class="navbar-nav ml-auto">
            <li class="nav-item active">
              <a class="nav-link" href="index.html">
                <img src="images/icons/home-icon.png" width="30">
              </a>
            </li>
            <li class="nav-item active">
              <a class="nav-link" href="pkr-activator-pipeline.html">
                <img src="images/icons/pipeline-icon.png" width="30">
              </a>
            </li>
          </ul>
      </div>
    </nav>
    <main class="pipeline-details">
      <div class="container">
        <div class="row">
          <div class="col-sm-9 col-7">
            <h1 class="mb-4">Thalassemia ph2</h1>
          </div>
          <div class="col-sm-3 col-5">
            <span class="badge blue-dark float-right mt-1">Status: Completed</span>
          </div>

          <div class="col-md-12">
            <p>This phase 2, open-label, multicenter study investigated the efficacy and safety of mitapivat in both α-thalassemia and β-thalassemia</p>
            
            <div class="block">
              <div class="row">
                <div class="col-md-12">
                  <img src="images/thalassemia-ph2.png" />
                </div>
              </div>
              <div class="row">
                <div class="col-md-4">
                  <p><strong>Key inclusion criteria:</strong></p>
                  <ul class="mb-4 pl-20">
                    <li>β-thalassemia ± α-globin gene mutations, HbE β-thalassemia, or α-thalassemia (HbH disease)</li>
                    <li>Hb ≤ 10.0 g/dL</li>
                    <li>Non–transfusion-dependentb</li>
                  </ul>
                </div>
                <div class="col-md-4">
                  <p><strong>Primary endpoint<sup>c</sup></strong></p>
                  <ul class="mb-4 pl-20">
                    <li>Hb response, defined as increase of ≥ 1.0 g/dL from baseline at any time between Weeks 4–12, inclusive</li>
                  </ul>
                </div>
                <div class="col-md-4">
                  <p><strong>Secondary and exploratory endpoints</strong></p>
                  <ul class="mb-4 pl-20">
                    <li>Sustained Hb response; delayed Hb response; markers of hemolysis and erythropoiesis; safety</li>
                  </ul>
                </div>
              </div>
            </div>

          </div>
        </div>
        <footer>
            <div class="row">
              <div class="col-md-12">
                <p class="text-left mb-4">aFully enrolled; b≤ 5 RBC units transfused in the preceding 24 weeks and none in the 8 weeks prior to study drug; cWith the originally planned sample size of 17 patients, the study would have 80% power to reject a ≤ 30% response rate at a one-sided 0.05 type 1 error rate.<br/>
                BID = twice daily; dL = deciliter; Hb = hemoglobin; HbE = hemoglobin E; HbH = hemoglobin H; g = gram; n = number; RBC = red blood cell.</p>
                <p class="text-right">EudraCT 2018‐002217‐35; ClinicalTrials.gov: NCT03692052<br/>
                For more information (physician/HCP only),<br/>
                please email medinfo@agios.com<br/>
                ©2021 Agios Pharmaceuticals, Inc. All rights reserved.</p>
              </div>
            </div>
        </footer>
      </div>
    </main>


    <!-- Optional JavaScript -->
    <!-- jQuery first, then Popper.js, then Bootstrap JS -->
    <!-- <script src="https://code.jquery.com/jquery-3.2.1.slim.min.js" integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.12.9/umd/popper.min.js" integrity="sha384-ApNbgh9B+Y1QKtv3Rn7W3mgPxhU9K/ScQsAP7hUibX39j7fakFPskvXusvfa0b4Q" crossorigin="anonymous"></script> -->
    <script src="js/jquery-3.4.1.min.js"></script>
    <script src="js/bootstrap.min.js"></script>
  </body>
</html>